Emcitate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Emcitate, covering 2024-12-13 to 2025-03-11. Get the full timeline:
Most recent: EMA Authorised: Emcitate (tiratricol) — Rare Thyroid Therapeutics International AB